LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • May 5th, 2021 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
This License and Collaboration Agreement (the “Agreement”) is entered into as of the Execution Date by and between Rigel Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 1180 Veterans Boulevard, South San Francisco, CA 94080 (“Rigel”), and Eli Lilly and Company, an Indiana corporation having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 96285 (“Lilly”). Rigel and Lilly are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
